Thomas C Hanff1, A Richey Sharrett, Thomas H Mosley, Dean Shibata, David S Knopman, Ronald Klein, Barbara E K Klein, Rebecca F Gottesman. 1. From the Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia (T.C.H.); Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (A.R.S., R.F.G.); Department of Medicine-Geriatrics, University of Mississippi Medical Center, Jackson (T.H.M.); Department of Radiology, University of Washington Medical Center, Seattle (D.S.); Department of Neurology, Mayo Clinic, Rochester, MN (D.S.K.); Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison (R.K., B.E.K.K.); and Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD (R.F.G.).
Abstract
BACKGROUND AND PURPOSE: Brain microvascular disease leads to leukoaraiosis and lacunar infarcts and contributes to risk of stroke and cognitive decline. Given a shared pathophysiology, retinal microvascular signs are expected to predict brain microvascular disease progression. We investigated if either leukoaraiosis volume progression measured continuously or combined with incident lacunar infarcts would better demonstrate expected associations with retinal disease than has previously been shown. METHODS: Eight hundred thirty participants in the Atherosclerosis Risk in Communities (ARIC) study aged ≥55 years and without previous stroke received an initial brain magnetic resonance imaging, retinal photography, and, 10 years later, a follow up magnetic resonance imaging. We evaluated retinal vascular sign phenotypes as predictors of (1) leukoaraiosis volume increase, and (2) a new score combining leukoaraiosis volume change and incident lacunar infarcts. Hypertension and diabetes mellitus were evaluated as confounders and effect modifiers. RESULTS: Individuals with any retinopathy (3.34 cm3; 95% confidence interval [CI], 0.74-5.96) or with arteriovenous nicking (2.61 cm3; 95% CI, 0.80-4.42) each had greater progression of leukoaraiosis compared with those without these conditions. Any retinopathy (odds ratio [OR], 3.18; 95% CI, 1.71-5.89) or its components-microaneurysms (OR, 3.06; 95% CI, 1.33-7.07) and retinal hemorrhage (OR, 3.02; 95% CI, 1.27-7.20)-as well as arteriovenous nicking (OR, 1.93; 95%, CI 1.24-3.02) and focal arteriolar narrowing (OR, 1.76; 95% CI, 1.19-2.59), were associated with a higher quartile of a novel brain microvascular disease score combining leukoaraiosis progression with incident subclinical lacunes. CONCLUSIONS: A novel scoring method revealed associations of retinal signs with leukoaraiosis progression and brain microvascular disease, which have not been shown before.
BACKGROUND AND PURPOSE:Brain microvascular disease leads to leukoaraiosis and lacunar infarcts and contributes to risk of stroke and cognitive decline. Given a shared pathophysiology, retinal microvascular signs are expected to predict brain microvascular disease progression. We investigated if either leukoaraiosis volume progression measured continuously or combined with incident lacunar infarcts would better demonstrate expected associations with retinal disease than has previously been shown. METHODS: Eight hundred thirty participants in the Atherosclerosis Risk in Communities (ARIC) study aged ≥55 years and without previous stroke received an initial brain magnetic resonance imaging, retinal photography, and, 10 years later, a follow up magnetic resonance imaging. We evaluated retinal vascular sign phenotypes as predictors of (1) leukoaraiosis volume increase, and (2) a new score combining leukoaraiosis volume change and incident lacunar infarcts. Hypertension and diabetes mellitus were evaluated as confounders and effect modifiers. RESULTS: Individuals with any retinopathy (3.34 cm3; 95% confidence interval [CI], 0.74-5.96) or with arteriovenous nicking (2.61 cm3; 95% CI, 0.80-4.42) each had greater progression of leukoaraiosis compared with those without these conditions. Any retinopathy (odds ratio [OR], 3.18; 95% CI, 1.71-5.89) or its components-microaneurysms (OR, 3.06; 95% CI, 1.33-7.07) and retinal hemorrhage (OR, 3.02; 95% CI, 1.27-7.20)-as well as arteriovenous nicking (OR, 1.93; 95%, CI 1.24-3.02) and focal arteriolar narrowing (OR, 1.76; 95% CI, 1.19-2.59), were associated with a higher quartile of a novel brain microvascular disease score combining leukoaraiosis progression with incident subclinical lacunes. CONCLUSIONS: A novel scoring method revealed associations of retinal signs with leukoaraiosis progression and brain microvascular disease, which have not been shown before.
Authors: David J Couper; Ronald Klein; Larry D Hubbard; Tien Yin Wong; Paul D Sorlie; Lawton S Cooper; Rosemary J Brothers; F Javier Nieto Journal: Am J Ophthalmol Date: 2002-01 Impact factor: 5.258
Authors: L D Hubbard; R J Brothers; W N King; L X Clegg; R Klein; L S Cooper; A R Sharrett; M D Davis; J Cai Journal: Ophthalmology Date: 1999-12 Impact factor: 12.079
Authors: M Haan; M A Espeland; B E Klein; R Casanova; S A Gaussoin; R D Jackson; A E Millen; S M Resnick; J E Rossouw; S A Shumaker; R Wallace; K Yaffe Journal: Neurology Date: 2012-03-14 Impact factor: 9.910
Authors: R Klein; A R Sharrett; B E Klein; L E Chambless; L S Cooper; L D Hubbard; G Evans Journal: Arterioscler Thromb Vasc Biol Date: 2000-06 Impact factor: 8.311
Authors: T A Manolio; R A Kronmal; G L Burke; V Poirier; D H O'Leary; J M Gardin; L P Fried; E P Steinberg; R N Bryan Journal: Stroke Date: 1994-02 Impact factor: 7.914
Authors: Tien Yin Wong; Ronald Klein; A Richey Sharrett; David J Couper; Barbara E K Klein; Duan-Ping Liao; Larry D Hubbard; Thomas H Mosley Journal: JAMA Date: 2002-07-03 Impact factor: 56.272
Authors: Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans Journal: Lancet Neurol Date: 2013-08 Impact factor: 44.182
Authors: Alexander Pinhas; Moataz Razeen; Michael Dubow; Alexander Gan; Toco Y Chui; Nishit Shah; Mitul Mehta; Ronald C Gentile; Rishard Weitz; Joseph B Walsh; Yusufu N Sulai; Joseph Carroll; Alfredo Dubra; Richard B Rosen Journal: Invest Ophthalmol Vis Sci Date: 2014-11-20 Impact factor: 4.799
Authors: Aaron R Folsom; Pamela L Lutsey; Ronald Klein; Barbara E Klein; Weihong Tang Journal: Ophthalmic Epidemiol Date: 2017-12-27 Impact factor: 1.648
Authors: Chao Yang; Lucia Kwak; Shoshana H Ballew; Bernard G Jaar; Jennifer A Deal; Aaron R Folsom; Gerardo Heiss; A Richey Sharrett; Elizabeth Selvin; Charumathi Sabanayagam; Josef Coresh; Kunihiro Matsushita Journal: Atherosclerosis Date: 2019-10-11 Impact factor: 5.162
Authors: Sara B Seidelmann; Brian Claggett; Paco E Bravo; Ankur Gupta; Hoshang Farhad; Barbara E Klein; Ronald Klein; Marcelo Di Carli; Scott D Solomon Journal: Circulation Date: 2016-09-28 Impact factor: 29.690
Authors: Silvia Koton; Andrea L C Schneider; B Gwen Windham; Thomas H Mosley; Rebecca F Gottesman; Josef Coresh Journal: Stroke Date: 2020-10-01 Impact factor: 7.914